Creso Pharma (ASX:CPH) welcomes the Royal Commission and clinical studies on psilocybin, page-51

This has lost more than 50% of it's value from its peak. There's been a lot of hype and BS spread around, and who could blame people for jumping in when it was in its 20's? It actually looked like a good proposition - until you looked more into the company and the rest of the market.

I pity people who got in high, but it's got more to go down yet. Another bone of contention is with all the utterly useless announcements - I have never ever seen a company put out so much crap about nothing, and the only conclusion I can draw is that they are just trying to feed into the hype and keep it going.

I'm neither disgruntled or overly ecstatic, but on the other hand, you seem to be way too exuberant for a company which has lost over 50% of its value in a short space of time.